Quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR study

被引：0

作者：

Karthaus, M. ^{[1
]}

Kretzschmar, A. ^{[2
]}

Welslau, M. ^{[3
]}

Riera-Knorrenschild, J. ^{[4
]}

Kaiser, F. ^{[5
]}

Pelz, H. ^{[6
]}

Ettrich, T. ^{[7
]}

Lindig, U. ^{[8
]}

Schulz, H. ^{[9
]}

von Weikersthal, Fischer L. ^{[10
]}

Kisro, J. ^{[11
]}

de Wit, M. ^{[12
]}

Wiebe, S. ^{[13
]}

Koenigsmann, M. ^{[14
]}

Mahlberg, R. ^{[15
]}

Fuxius, S. ^{[16
]}

Stehle, I ^{[17
]}

Kubicka, S. ^{[18
]}

Schuler, M. K. ^{[19
]}

Schnoy, E. ^{[20
]}

Ruessel, J. ^{[21
]}

Graefe, T. ^{[22
]}

Mayer, F. ^{[23
]}

Berres, M. L. ^{[24
]}

Kubin, T. ^{[25
]}

Heinemann, V ^{[26
]}

机构：

[1] Klinikum Neuperlach Klinikum Harlaching, Hamatol & Onkol, Munich, Germany

[2] MVZ Mitte, Leipzig, Germany

[3] Praxis Hamatol & Onkol, Aschaffenburg, Germany

[4] Univ Klin, Giessen, Germany

[5] Praxis Hamatol & Onkol, Landshut, Germany

[6] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany

[7] Univ Klin Innere Med, Ulm, Germany

[8] Univ Jena, Med Klin 2, Jena, Germany

[9] PIOH Praxis Internist Onkol & Hamatol, Frechen, Germany

[10] Gesundheitszentrum St Marien, Amberg, Germany

[11] Onkol Schwerpunktpraxis, Lubeck, Germany

[12] Klin Innere Med Hamatol Onkol & Palliat Med, Berlin, Germany

[13] MVZ Media Vita, Munster, Germany

[14] MediProjekt, Hannover, Germany

[15] Klinikum Borromaerinnen, Innere Med 1, Trier, Germany

[16] Tumor Ctr, Heidelberg, Germany

[17] IDGGQ, Kaiserslautern, Germany

[18] Klinikum Steinberg, Reutlingen, Germany

[19] MVZ Oskar Helene Heim, Berlin, Germany

[20] Klinikum Augsburg, Augsburg, Germany

[21] Carl von Basedow Klinikum, Merseburg, Germany

[22] Forsch Gesell Malignitat & Resultate, Hamburg, Germany

[23] Int Gemeinschaftspraxis, Friedrichshafen, Germany

[24] Univ Klin RWTH, Aachen, Germany

[25] Hamatol Onkol Klinikum Traunstein, Traunstein, Germany

[26] Med Klin III, Munich, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ep317

引用

页码：219 / 219

页数：1

共 50 条

[41] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study
Li, Rongrong
Zhou, Hui-Jun
Zeng, De-Yu
Jiang, Shao-Feng
Liu, Wu
Liu, Zhen-yang
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[42] Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
Chida, Keigo
Kotani, Daisuke
Nakamura, Yoshiaki
Kawazoe, Akihito
Kuboki, Yasutoshi
Shitara, Kohei
Kojima, Takashi
Taniguchi, Hiroya
Watanabe, Jun
Endo, Itaru
Yoshino, Takayuki
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[43] Economic Sustainability of Trifluridine/Tipiracil for the Treatment of Refractory Metastatic Colorectal Cancer in Real Life
Giuliani, Jacopo
Bonetti, Andrea
CLINICAL COLORECTAL CANCER, 2020, 19 (04) : E181 - E182
[44] Retrospective cohort study of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer: A real-world data from 4 hospitals in Portugal
Menezes, M.
Araujo, J.
Fonseca, F.
da Silva, D. Neto
Trabulo, C.
Dunoes, I.
Baio, G.
Bastos, I.
Oliveira, A.
Inacio, M.
Dinis, R.
ANNALS OF ONCOLOGY, 2023, 34 : S119 - S120
[45] Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil plus bevazicumab: Final analysis from a Danish randomised study
Pfeiffer, P.
Winther, S.
Moller, S.
Poulsen, L.
Yilmaz, M.
Qvortrup, C.
ANNALS OF ONCOLOGY, 2023, 34 : S101 - S101
[46] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Kotani, Daisuke
Kuboki, Yasutoshi
Horasawa, Satoshi
Kaneko, Asumi
Nakamura, Yoshiaki
Kawazoe, Akihito
Bando, Hideaki
Taniguchi, Hiroya
Shitara, Kohei
Kojima, Takashi
Tsuji, Akihito
Yoshino, Takayuki
BMC CANCER, 2019, 19 (01)
[47] Cost-Utility Analysis of Trifluridine/ Tipiracil in treating Metastatic Colorectal Cancer in Previously Treated Patients in Jordan
Al Rabayah, Abeer
Sawalha, Razan
Jaddoua, Saad
MEDICAL DECISION MAKING, 2024, 44 (02) : NP90 - NP91
[48] Health-related quality of life in the early-access phase IIIb study of trifluridine/tipiracil in pretreated metastatic colorectal cancer (mCRC): Results from PRECONNECT study.
Taieb, Julien
Price, Timothy Jay
Ciardiello, Fortunato
Peeters, Marc
Wyrwicz, Lucjan
Bachet, Jean-Baptiste
Borg, Christophe
De la Fouchardiere, Christelle
Becquart, Martin
Mounedji, Nadjat
Vidot, Loick
Sabater, Javier
Falcone, Alfredo
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[49] Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
Bullement, Ash
Underhill, Stuart
Fougeray, Ronan
Hatswell, Anthony James
CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E143 - E151
[50] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
Samawi, H. H.
Brezden-Masley, C.
Afzal, A. R.
Cheung, W. Y.
Dolley, A.
CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +

← 1 2 3 4 5 →